Ameriprise Financial Inc Acadia Pharmaceuticals Inc Transaction History

Ameriprise Financial Inc

$358 Billion
Q1 2024

A detailed history of Ameriprise Financial Inc transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Ameriprise Financial Inc holds 742,183 shares of ACAD stock, worth $12.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

742,183

Previous 647,112 14.69%

Holding current value

$12.1 Million

Previous $20.3 Million 32.27%

% of portfolio

0.0%

Previous 0.01%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$17.79 - $30.86 $1.69 Million - $2.93 Million	95,071 Added 14.69%	742,183 $13.7 Million
Q4 2023 Feb 14, 2024	BUY	$20.78 - $31.77 $1.4 Million - $2.15 Million	67,605 Added 11.67%	647,112 $20.3 Million
Q3 2023 Nov 14, 2023	BUY	$20.84 - $33.47 $238,847 - $383,599	11,461 Added 2.02%	579,507 $12.1 Million
Q2 2023 Aug 14, 2023	SELL	$17.8 - $25.65 $221,236 - $318,803	-12,429 Reduced 2.14%	568,046 $13.6 Million
Q1 2023 May 15, 2023	BUY	$16.32 - $20.92 $933,161 - $1.2 Million	57,179 Added 10.93%	580,475 $10.9 Million

Q4 2022 Feb 14, 2023	SELL	$14.2 - $18.63 $5.77 Million - $7.57 Million	-406,511 Reduced 43.72%	523,296 $8.33 Million
Q3 2022 Nov 14, 2022	SELL	$14.11 - $18.27 $215,219 - $278,672	-15,253 Reduced 1.61%	929,807 $15.2 Million
Q2 2022 Aug 15, 2022	SELL	$13.01 - $27.22 $1.75 Million - $3.66 Million	-134,481 Reduced 12.46%	945,060 $13.3 Million
Q1 2022 May 16, 2022	SELL	$20.94 - $27.5 $1.65 Million - $2.17 Million	-78,757 Reduced 6.8%	1,079,541 $26.1 Million
Q4 2021 Feb 14, 2022	BUY	$16.79 - $27.09 $495,607 - $799,642	29,518 Added 2.62%	1,158,298 $27 Million
Q3 2021 Nov 15, 2021	SELL	$15.78 - $24.77 $2.68 Million - $4.21 Million	-169,958 Reduced 13.09%	1,128,780 $18.8 Million
Q2 2021 Aug 16, 2021	SELL	$19.4 - $27.42 $22 Million - $31.1 Million	-1,135,313 Reduced 46.64%	1,298,738 $31.7 Million
Q1 2021 May 17, 2021	BUY	$25.02 - $54.99 $29.2 Million - $64.3 Million	1,168,541 Added 92.34%	2,434,051 $62.8 Million
Q4 2020 Feb 12, 2021	BUY	$41.04 - $56.79 $2.03 Million - $2.81 Million	49,503 Added 4.07%	1,265,510 $67.7 Million
Q3 2020 Nov 16, 2020	SELL	$36.42 - $57.0 $34.6 Million - $54.2 Million	-950,967 Reduced 43.88%	1,216,007 $50.2 Million
Q2 2020 Aug 14, 2020	BUY	$39.26 - $52.73 $22.6 Million - $30.3 Million	574,958 Added 36.12%	2,166,974 $105 Million
Q1 2020 May 15, 2020	BUY	$31.65 - $46.87 $22.6 Million - $33.5 Million	713,916 Added 81.3%	1,592,016 $67.3 Million
Q4 2019 Feb 14, 2020	SELL	$36.21 - $51.4 $4.43 Million - $6.29 Million	-122,394 Reduced 12.23%	878,100 $37.6 Million
Q3 2019 Nov 14, 2019	BUY	$22.22 - $44.01 $11.8 Million - $23.4 Million	530,622 Added 112.93%	1,000,494 $36 Million
Q2 2019 Aug 14, 2019	SELL	$23.32 - $28.12 $1.46 Million - $1.77 Million	-62,797 Reduced 11.79%	469,872 $12.6 Million
Q1 2019 May 15, 2019	BUY	$16.17 - $27.38 $2.72 Million - $4.6 Million	168,178 Added 46.14%	532,669 $14.3 Million
Q4 2018 Feb 14, 2019	SELL	$14.32 - $22.92 $6,716 - $10,749	-469 Reduced 0.13%	364,491 $5.89 Million
Q3 2018 Nov 14, 2018	SELL	$13.03 - $21.81 $7.52 Million - $12.6 Million	-577,268 Reduced 61.27%	364,960 $7.56 Million
Q2 2018 Aug 14, 2018	BUY	$15.07 - $22.34 $1.07 Million - $1.58 Million	70,908 Added 8.14%	942,228 $14.4 Million
Q1 2018 May 15, 2018	BUY	$22.47 - $32.33 $570,288 - $820,535	25,380 Added 3.0%	871,320 $19.6 Million
Q4 2017 Feb 12, 2018	SELL	$26.84 - $39.14 $1.24 Million - $1.8 Million	-46,066 Reduced 5.16%	845,940 $25.5 Million
Q3 2017 Nov 07, 2017	BUY	$29.49 - $38.37 $26.3 Million - $34.2 Million	892,006	892,006 $33.6 Million

Others Institutions Holding ACAD

# of Institutions

299

Shares Held

158M

Call Options Held

1.88M

Put Options Held

688K

View Full List

About ACADIA PHARMACEUTICALS INC

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.63B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

More about ACAD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Account

Ameriprise Financial Inc Acadia Pharmaceuticals Inc Transaction History